Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 21 | 171 | 21 | 0 | 133 |
| Gross Profit | 21 | 171 | 21 | N/A | 133 |
| Operating Expenses | 16,469 | 13,883 | 12,169 | 9,321 | 7,003 |
| Operating Income | -16,448 | -13,712 | -12,148 | -9,321 | -6,870 |
| Other Income | 17 | 18 | 2 | 0 | 1 |
| Pre-tax Income | -16,431 | -13,694 | -12,146 | -9,321 | -6,869 |
| Net Income Continuous | -16,431 | -13,694 | -12,146 | -9,321 | -6,869 |
| Net Income | $-16,431 | $-13,694 | $-12,146 | $-9,321 | $-6,869 |
| EPS Basic Total Ops | -8.25 | -6.90 | 51.72 | -54.87 | -42.88 |
| EPS Basic Continuous Ops | -8.31 | -6.93 | 51.66 | -54.91 | -42.84 |
| EPS Diluted Total Ops | -8.25 | -6.90 | 51.72 | -54.87 | -42.88 |
| EPS Diluted Continuous Ops | -8.31 | -6.93 | 51.66 | -54.91 | -42.84 |
| EBITDA(a) | $-16,406 | $-13,669 | $-12,110 | $-9,284 | $-6,835 |